Midlife Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
as on 06-12-2024
- Paid Up Capital ₹ 0.80 M
as on 06-12-2024
- Company Age 18 Year, 3 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 3.17%
(FY 2020)
- Profit 164.96%
(FY 2020)
- Ebitda 33.08%
(FY 2020)
- Net Worth 8.20%
(FY 2020)
- Total Assets 1.78%
(FY 2020)
About Midlife Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.80 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Singh and Vinod Singh serve as directors at the Company.
- CIN/LLPIN
U24232UP2006PTC032662
- Company No.
032662
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Dec 2006
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Midlife Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Singh  | Director | 16-May-2007 | Current |
| Vinod Singh | Director | 22-Dec-2006 | Current |
Financial Performance of Midlife Biosciences.
Midlife Biosciences Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 3.17% increase. The company also saw a substantial improvement in profitability, with a 164.96% increase in profit. The company's net worth moved up by a moderate rise of 8.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Midlife Biosciences?
In 2020, Midlife Biosciences had a promoter holding of 90.38% and a public holding of 9.62%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Midlife Biosciences?
Unlock and access historical data on people associated with Midlife Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Midlife Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Midlife Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
